<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<atom:link href="https://wfneurology.org/activities/news-events/neurology-news/neurology-news-covid-19?method_call=showRSS" rel="self" type="application/xml" />
		<title>Neurology News - Covid-19</title>
		<link>https://wfneurology.org/activities/news-events/neurology-news/neurology-news-covid-19</link>
					<description>Neurology News, Covid-19</description>
						
					<item>
									<title>The Secrets of Covid ‘Brain Fog’ Are Starting to Lift</title>
				
									<description>












































Scientists are getting closer to understanding the neurology behind the memory problems and cognitive fuzziness that an infection can trigger.












































</description>
				
									<link>https://wfneurology.org/activities/news-events/archived-news/2022-07-01-wired</link>
				
				
				
							</item>
					<item>
									<title>Brain regions related to smell show decline following mild COVID-19</title>
				
									<description>








































































Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.








































































</description>
				
									<link>https://wfneurology.org/activities/news-events/archived-news/2022-03-07-university-of-oxford</link>
				
				
				
							</item>
					<item>
									<title>WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission</title>
				
									<description>
































































The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalisation, says a WHO Guideline Development Group of international experts in The BMJ today.
































































</description>
				
									<link>https://wfneurology.org/activities/news-events/archived-news/2022-03-03-bmj</link>
				
				
				
							</item>
					<item>
									<title>COVID-19’s Impact on the Brain Is a Key Topic of the 25th Biennial World Congress of Neurology</title>
				
									<description>The neurological impact of COVID-19, biomarkers for traumatic brain injury and migraine pathophysiology were among the many topics discussed at the XXV Biennial World Congress of Neurology on October 3 through 7, 2021, presented by the World Federation of Neurology.</description>
				
									<link>https://wfneurology.org/activities/news-events/archived-news/2021-10-03-wfn-wcn</link>
				
				
				
							</item>
			</channel>
</rss>